Ritedose Corp. Plans To Expand Its Production Facility In Richland County, South Carolina
The expansion is expected to cost up to $110-million and could add more than 80,000 square feet of space to the company's existing 120,000-square-foot manufacturing and packaging facility in a phased manner. It is also expected to create more than 65 jobs over five years. Execution of the expansion plan will be contingent upon regulatory approval of the products and the facilities by the U.S. Food and Drug Administration.
The Ritedose Corp. specializes in manufacturing inhalation products, eye drops, ear drops and unit dose oral liquids, with expertise in blow-fill seal technology. The company's existing plant has a capacity of more than one billion unit dose vials each year. Upon completion of the expansion, that figure would exceed two billion unit dose vials annually.
In addition to its manufacturing and packaging operations, The Ritedose Corp. also conducts research and development activities in Columbia aimed at product development and process improvement. The Ritedose Corp. will be working with readySC to screen and hire skilled positions for the facility.
"Through this planned expansion, The Ritedose Corp. will be able to better respond to the capacity and capability needs of our existing and new clients serving both U.S. and overseas markets over the next five years. Since 1995, the State of South Carolina's commitment to our success has allowed our company to continue to expand, and we appreciate the support of Governor Haley and the state and local officials who were instrumental in today's announcement,” said Dr. Umesh Dalvi, President/CEO of The Ritedose Corp.
"After establishing operations in our state nearly two decades ago, we are thrilled that The Ritedose Corporation continues to grow and succeed here. This major expansion once again demonstrates that South Carolina is a place where pharmaceutical companies want to do business, and we applaud their investment and the new jobs they are bringing to Richland County,” Governor Nikki Haley said.
Beam Therapeutics Selects Research Triangle Park, North Carolina, for Research and Production Campus
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
How are Uncertain Times Altering Company Location Strategies?
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
A Heightened Focus on Reshoring
34th Annual Corporate Survey & the 16th Annual Consultants Survey